ES2336130T3 - Derivados 1-(hetero)aril-3-amino-pirrolidina para uso como antagonistas del receptor de mglur3. - Google Patents
Derivados 1-(hetero)aril-3-amino-pirrolidina para uso como antagonistas del receptor de mglur3. Download PDFInfo
- Publication number
- ES2336130T3 ES2336130T3 ES05804465T ES05804465T ES2336130T3 ES 2336130 T3 ES2336130 T3 ES 2336130T3 ES 05804465 T ES05804465 T ES 05804465T ES 05804465 T ES05804465 T ES 05804465T ES 2336130 T3 ES2336130 T3 ES 2336130T3
- Authority
- ES
- Spain
- Prior art keywords
- mmol
- group
- pyrrolidin
- compound
- amine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/41—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by hydrogenolysis or reduction of carboxylic groups or functional derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61978904P | 2004-10-18 | 2004-10-18 | |
| US619789P | 2004-10-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2336130T3 true ES2336130T3 (es) | 2010-04-08 |
Family
ID=35787981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES05804465T Expired - Lifetime ES2336130T3 (es) | 2004-10-18 | 2005-10-13 | Derivados 1-(hetero)aril-3-amino-pirrolidina para uso como antagonistas del receptor de mglur3. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7868014B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1805165B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5188807B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN101094846A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE452130T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2005295860A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0516602A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2584422A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE602005018381D1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2336130T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2007004661A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006044454A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1757582T3 (en) * | 2004-05-28 | 2016-02-01 | Mitsubishi Tanabe Pharma Corp | Arylalkylamines AND MANUFACTURING METHOD THEREOF |
| FR2928150A1 (fr) | 2008-02-29 | 2009-09-04 | Vetoquinol Sa Sa | Nouveaux derives 7-substitues de 3-carboxy-oxadiazino-quinolones, leur preparation et leur application comme anti-bacteriens |
| WO2009131196A1 (ja) * | 2008-04-24 | 2009-10-29 | 武田薬品工業株式会社 | 置換ピロリジン誘導体およびその用途 |
| EP2145891A1 (en) | 2008-07-09 | 2010-01-20 | Vetoquinol S.A. | 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials |
| TW201022233A (en) * | 2008-11-04 | 2010-06-16 | Organon Nv | (Pyrrolidin-2-yl)phenyl derivatives |
| US10154988B2 (en) | 2012-11-14 | 2018-12-18 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
| WO2016092002A1 (en) | 2014-12-11 | 2016-06-16 | Janssen Pharmaceutica Nv | 1,2,4-triazolo[4,3-a]pyridine compounds and their use as positive allosteric modulators of mglur2 receptors |
| CN113024412A (zh) * | 2021-03-23 | 2021-06-25 | 上海立科化学科技有限公司 | 2,4,6-三氯苯腈的制备方法 |
| CN114149297A (zh) * | 2021-12-07 | 2022-03-08 | 北京中医药大学 | 一种微波辅助的选择性芳基甲醛的绿色合成方法 |
| CN115368283A (zh) * | 2022-09-15 | 2022-11-22 | 丽水绿氟科技有限公司 | 一种手性结构或非手性结构的顺式-3-氟-4-羟基吡咯烷及其衍生物的制备方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5001125A (en) * | 1984-03-26 | 1991-03-19 | Janssen Pharmaceutica N.V. | Anti-virally active pyridazinamines |
| US4785119A (en) * | 1985-10-11 | 1988-11-15 | Tokyo Kasei Kogyo Co., Ltd. | 3-aminopyrrolidine compound and process for preparation thereof |
| US5232929A (en) | 1990-11-28 | 1993-08-03 | Pfizer Inc. | 3-aminopiperidine derivatives and related nitrogen containing heterocycles and pharmaceutical compositions and use |
| WO1991009844A1 (en) | 1990-01-04 | 1991-07-11 | Pfizer Inc. | Substance p antagonists |
| US5332817A (en) * | 1990-01-04 | 1994-07-26 | Pfizer Inc. | 3-aminopiperidine derivatives and related nitrogen containing heterocycles |
| TW202432B (cg-RX-API-DMAC7.html) * | 1991-06-21 | 1993-03-21 | Pfizer | |
| US5686482A (en) * | 1994-04-28 | 1997-11-11 | Yamanouchi Pharmaceutical Co., Ltd. | N-(3-pyrrolidinyl) benzamide derivative |
| ES2079323B1 (es) * | 1994-06-21 | 1996-10-16 | Vita Invest Sa | Derivados de indol utiles para el tratamiento de la migraña, composicion y uso correspondientes. |
| DE19524765A1 (de) * | 1995-07-07 | 1997-01-09 | Boehringer Mannheim Gmbh | Neue Oxazolidinonderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| ES2237788T3 (es) | 1996-01-22 | 2005-08-01 | Eli Lilly And Company | Derivados de indano para composiciones antipsicoticas. |
| AU1608397A (en) | 1996-02-02 | 1997-08-22 | Zeneca Limited | Heterocyclic compounds useful as pharmaceutical agents |
| US5891889A (en) * | 1996-04-03 | 1999-04-06 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| JP2001515839A (ja) * | 1997-07-18 | 2001-09-25 | ジョージタウン・ユニバーシティ | 二環式向代謝性グルタミン酸受容体リガンド |
| JP2001510797A (ja) | 1997-07-22 | 2001-08-07 | イーライ・リリー・アンド・カンパニー | 医薬化合物 |
| US20010006972A1 (en) | 1998-04-21 | 2001-07-05 | Stephen A. Williams | Nk-1 receptor antagonists for the treatment of symptoms of irritable bowel syndrome |
| WO1999064396A1 (en) * | 1998-06-09 | 1999-12-16 | Neurogen Corporation | Substituted 1-aryl-3-benzylaminopyrrolidine: dopamine receptor subtype specific ligands |
| AU2002342414A1 (en) * | 2001-05-10 | 2002-11-25 | Aventis Pharma Deutschland Gmbh | Novel processes for the preparation of adenosine compounds and intermediates thereto |
| WO2004060308A2 (en) * | 2002-12-27 | 2004-07-22 | Chiron Corporation | Thiosemicarbazones as anti-virals and immunopotentiators |
| DE10306250A1 (de) | 2003-02-14 | 2004-09-09 | Aventis Pharma Deutschland Gmbh | Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| ES2305776T3 (es) | 2003-06-17 | 2008-11-01 | Pfizer Inc. | Derivados de n-pirrolidin-3-il-amida como inhibidores de la re-captacion de serotonina y noradrenalina. |
| US7348434B2 (en) * | 2003-08-08 | 2008-03-25 | Antony Bigot | 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them |
| CA2539335A1 (en) * | 2003-10-31 | 2005-05-12 | Otsuka Pharmaceutical Co., Ltd. | 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis |
| DK1757582T3 (en) * | 2004-05-28 | 2016-02-01 | Mitsubishi Tanabe Pharma Corp | Arylalkylamines AND MANUFACTURING METHOD THEREOF |
-
2005
- 2005-10-13 AT AT05804465T patent/ATE452130T1/de not_active IP Right Cessation
- 2005-10-13 JP JP2007536836A patent/JP5188807B2/ja not_active Expired - Fee Related
- 2005-10-13 CA CA002584422A patent/CA2584422A1/en not_active Abandoned
- 2005-10-13 DE DE602005018381T patent/DE602005018381D1/de not_active Expired - Lifetime
- 2005-10-13 ES ES05804465T patent/ES2336130T3/es not_active Expired - Lifetime
- 2005-10-13 MX MX2007004661A patent/MX2007004661A/es not_active Application Discontinuation
- 2005-10-13 EP EP05804465A patent/EP1805165B1/en not_active Expired - Lifetime
- 2005-10-13 WO PCT/US2005/036665 patent/WO2006044454A1/en not_active Ceased
- 2005-10-13 CN CNA200580035313XA patent/CN101094846A/zh active Pending
- 2005-10-13 BR BRPI0516602-0A patent/BRPI0516602A/pt not_active IP Right Cessation
- 2005-10-13 US US11/576,960 patent/US7868014B2/en not_active Expired - Fee Related
- 2005-10-13 AU AU2005295860A patent/AU2005295860A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MX2007004661A (es) | 2007-06-22 |
| CA2584422A1 (en) | 2006-04-27 |
| JP2008516959A (ja) | 2008-05-22 |
| BRPI0516602A (pt) | 2008-09-16 |
| DE602005018381D1 (de) | 2010-01-28 |
| US20080300266A1 (en) | 2008-12-04 |
| WO2006044454A1 (en) | 2006-04-27 |
| EP1805165B1 (en) | 2009-12-16 |
| US7868014B2 (en) | 2011-01-11 |
| CN101094846A (zh) | 2007-12-26 |
| JP5188807B2 (ja) | 2013-04-24 |
| EP1805165A1 (en) | 2007-07-11 |
| ATE452130T1 (de) | 2010-01-15 |
| AU2005295860A1 (en) | 2006-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2021203497B2 (en) | Pyran derivatives as cyp11a1 (cytochrome p450 monooxygenase 11a1) inhibitors | |
| CN102741240B (zh) | 用作δ阿片类受体调节剂的嘧啶化合物 | |
| EP1591443B1 (en) | Pyrazole derivative | |
| WO2020006497A1 (en) | Inhibitors of cyclin-dependent kinases | |
| JP5562866B2 (ja) | 鉱質コルチコイド受容体アンタゴニストおよび使用方法 | |
| ES2564884T3 (es) | Derivados de etinilo como moduladores alostéricos de mGluR5 | |
| CN102030750A (zh) | 用作CB1受体配体的新四氢-1H-吡啶并[4,3-b]吲哚衍生物 | |
| CN101155797A (zh) | 在2-位上被一个季碳原子取代的1h-苯并咪唑-4-甲酰胺化合物是有效的parp抑制剂 | |
| CN101951904A (zh) | 苯并噻唑和苯并*唑衍生物以及使用方法 | |
| TW201434838A (zh) | 三唑并吡□ | |
| KR20150042269A (ko) | N형 칼슘 채널 차단제로서의 치환된 피라졸 | |
| ES2336130T3 (es) | Derivados 1-(hetero)aril-3-amino-pirrolidina para uso como antagonistas del receptor de mglur3. | |
| AU2008240728B2 (en) | 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists | |
| EP1912968A1 (en) | Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds | |
| AU2005291085A1 (en) | 5-sulfonyl-1-piperidinyl substituted indole derivatives as 5-HT6 receptor antagonists for the treatment of CNS disorders | |
| ES2546317T3 (es) | Derivados de 2-oxo-piperidinilo | |
| TWI726916B (zh) | 治療性化合物及其使用方法 | |
| ES2400710T3 (es) | Tia(dia)zoles como antagonistas del receptor de dopamina 2 de disociación rápida | |
| AU2008240727B2 (en) | Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists | |
| ES2345841T3 (es) | Derivados de pirazolo(3,4-d)azepina como antagonistas de histamina h3. | |
| CN102307853B (zh) | 作为nk3受体拮抗剂的吡咯烷衍生物 | |
| CN101365678A (zh) | 可用于治疗h3受体相关病症的h3受体调节剂 | |
| Perekhoda et al. | Synthesis and nootropic activity prediction of some 4-(aminomethyl)-1-benzylpyrrolidin-2-one derivatives structurally related with nebracetam | |
| HK1139674A (en) | Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists |